Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             115 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Analysis of image-guided superficial radiation therapy (IGSRT) on the treatment of early-stage non-melanoma skin cancer (NMSC) in the outpatient dermatology setting Tran, Alison

149 9 p. 6283-6291
artikel
2 Analysis of the cervical microbiome in women from the German national cervical cancer screening program Condic, Mateja

149 9 p. 6489-6500
artikel
3 Analytical dosimetric study of intensity-modulated radiotherapy (IMRT) and volumetric-modulated arc therapy (VMAT) for prostate cancer Samir, Fady

149 9 p. 6239-6246
artikel
4 An automatic classification of pulmonary nodules for lung cancer diagnosis using novel LLXcepNN classifier Gugulothu, Vijay Kumar

149 9 p. 6049-6057
artikel
5 A novel machine learning approach on texture analysis for automatic breast microcalcification diagnosis classification of mammogram images Sarvestani, Zahra Maghsoodzadeh

149 9 p. 6151-6170
artikel
6 Anticancer acumens of three Annona species: a proportional review Balkrishna, Acharya

149 9 p. 6693-6702
artikel
7 Antitumor activity of triazine mimic antibiotics for DNA-binding implications (impressive activity in vitro against a variety of tumor types in the NCI-60 screen): NSC 710607 to fight HCT-116 human colon carcinoma cell lines in vivo using the hollow fiber assay and xenograft mouse models Spychala, Jaroslaw

149 9 p. 6501-6511
artikel
8 Artificial intelligence in pancreatic cancer: diagnosis, limitations, and the future prospects—a narrative review Katta, Maanya Rajasree

149 9 p. 6743-6751
artikel
9 A single-institution retrospective analysis of intraoperative radiation boost during breast-conservation treatment for breast cancer Hochhertz, Franka

149 9 p. 5743-5749
artikel
10 Association between adjuvant therapy and survival in colorectal cancer patients according to metabolic Warburg-subtypes Offermans, Kelly

149 9 p. 6271-6282
artikel
11 Bacterial metabolite butyrate in modulating sorafenib-targeted microRNAs to curtail its resistance in hepatocellular carcinoma Kumar, Mukesh

149 9 p. 5823-5839
artikel
12 Bevacizumab biosimilar candidate TAB008 compared to Avastin® in patients with locally advanced, metastatic EGFR wild-type non-squamous non-small cell lung cancer: a randomized, double-blind, multicenter study Lu, S.

149 9 p. 5907-5914
artikel
13 Biological effects of cancer stem cells irradiated by charged particle: a systematic review of in vitro studies Wang, Qian

149 9 p. 6625-6638
artikel
14 Biomarker concordance between primary colorectal cancer and ovarian metastases: a Dutch cohort study van der Meer, Richard

149 9 p. 5677-5685
artikel
15 Breast cancer therapy in women under 35 years and between 50 and 69 years: influence of the observation period Schreiber, J.

149 9 p. 5665-5676
artikel
16 CACYBP knockdown inhibits progression of prostate cancer via p53 Li, Qiang

149 9 p. 5761-5772
artikel
17 Carbon ion irradiation induces DNA damage in melanoma and optimizes the tumor microenvironment based on the cGAS–STING pathway Guo, Yanan

149 9 p. 6315-6328
artikel
18 Cell-free circulating RAS mutation concentrations significantly impact the survival of metastatic colorectal cancer patients Muendlein, Axel

149 9 p. 6435-6444
artikel
19 Changes in the number of cancer diagnosis practices due to the COVID-19 pandemic: interrupted time-series analysis using the National Database of Japan Fujita, Misuzu

149 9 p. 6023-6033
artikel
20 Characteristics, treatment, and outcome of patients with bowel perforation after immune checkpoint inhibitor exposure Pizuorno Machado, Antonio

149 9 p. 5989-5998
artikel
21 Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case Chen, Min

149 9 p. 6361-6370
artikel
22 Clinical outcomes with atezolizumab plus bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter real-world study Persano, Mara

149 9 p. 5591-5602
artikel
23 Clinicopathological features of endoscopically treated early gastric cancer with lymphovascular infiltration Takano, Koji

149 9 p. 5781-5790
artikel
24 Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients Freiberger, Sandra N.

149 9 p. 5645-5653
artikel
25 Combined effects of vitamin D and neferine on the progression and metastasis of colorectal cancer Yang, Jinfeng

149 9 p. 6203-6210
artikel
26 Combining multiple cell death pathway-related risk scores to develop neuroblastoma cell death signature Han, Yahui

149 9 p. 6513-6526
artikel
27 Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma Moksud, Nafeesa

149 9 p. 6381-6390
artikel
28 Correlations between antimicrobial peptides and spectrophotometric skin color parameters in patients with basal cell carcinoma Fijałkowska, Marta

149 9 p. 5697-5704
artikel
29 Costs and clinical benefits of enhanced recovery after surgery (ERAS) in pancreaticoduodenectomy: an updated systematic review and meta-analysis Noba, Lyrics

149 9 p. 6639-6660
artikel
30 Digital twins in oncology Sager, Sebastian

149 9 p. 5475-5477
artikel
31 DOAC in the treatment of cancer-associated venous thromboembolism: a retrospective cohort study beyond the guidelines Cominacini, Mattia

149 9 p. 5773-5779
artikel
32 Driver and targetable alterations in Chinese patients with small bowel carcinoma Li, Jun

149 9 p. 6139-6150
artikel
33 Dual-layer spectral detector CT (SDCT) can improve the detection of mixed ground-glass lung nodules Zhang, Zhenghua

149 9 p. 5901-5906
artikel
34 Effect of antimicrobial therapy on progression-free survival of immunotherapy and chemo-/immunotherapy in patients with non-small cell lung cancer Uhlenbruch, Mark

149 9 p. 5915-5919
artikel
35 Efficacy and safety of interferon-alpha 1b combined with PD-1 monoclonal antibody in patients with unresectable stage IV melanoma: a retrospective study Zhu, Guannan

149 9 p. 6263-6269
artikel
36 Emerging glyco-risk prediction model to forecast response to immune checkpoint inhibitors in colorectal cancer Qiu, Peishan

149 9 p. 6411-6434
artikel
37 Endothelin-3 is epigenetically silenced in endometrioid endometrial cancer Zmarzły, Nikola

149 9 p. 5687-5696
artikel
38 Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomas Rodriguez-Cid, Jeronimo Rafael

149 9 p. 5479-5491
artikel
39 Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making Shi, Liu

149 9 p. 5999-6007
artikel
40 Exceptional response to neoadjuvant targeted therapy with the selective RET inhibitor selpercatinib in RET-fusion-associated sarcoma Schrenk, Karin G.

149 9 p. 5493-5496
artikel
41 Experience of individualized nursing in patients with laryngeal squamous cell carcinoma combined with Helicobacter pylori infection after surgery Wu, Li

149 9 p. 6575-6582
artikel
42 Extracranial metastasis sites correlate to the incidence risk of brain metastasis in stage IV non-small cell lung cancer: a population-based study Zhang, XiaoZhi

149 9 p. 6293-6301
artikel
43 Genetic analysis and clinicopathologic features of locally advanced papillary thyroid cancers: a prospective observational study Ding, Zheng

149 9 p. 6303-6313
artikel
44 HER2/neu-based vaccination with li-Key hybrid, GM-CSF immunoadjuvant and trastuzumab as a potent triple-negative breast cancer treatment Zhou, Yihan

149 9 p. 6711-6718
artikel
45 High-dose chemotherapy and autologous stem cell transplantation in primary lymphomatoid granulomatosis of the central nervous system Nilius-Eliliwi, Verena

149 9 p. 5729-5732
artikel
46 hnRNP K induces HPV16 oncogene expression and promotes cervical cancerization Lyu, Yuanjing

149 9 p. 6225-6237
artikel
47 Identification and validation of a PD-L1-related signature from mass spectrometry in gastric cancer Chen, Xiancong

149 9 p. 5871-5884
artikel
48 “I do not hear you!”: hearing-impaired cancer patients report their communication experiences Keck, Maximilian

149 9 p. 6557-6567
artikel
49 IL-2/GM-CSF enhances CXCR3 expression in CAR-T cells via the PI3K/AKT and ERK1/2 pathways Liu, Liwei

149 9 p. 5547-5557
artikel
50 Immune-related adverse events after immune checkpoint inhibitor exposure in adult cancer patients with pre-existing autoimmune diseases Pizuorno Machado, Antonio

149 9 p. 6341-6350
artikel
51 Immunological effects and activity of multiple doses of zolbetuximab in combination with zoledronic acid and interleukin-2 in a phase 1 study in patients with advanced gastric and gastroesophageal junction cancer Lordick, Florian

149 9 p. 5937-5950
artikel
52 Immunosuppressive role of SPP1-CD44 in the tumor microenvironment of intrahepatic cholangiocarcinoma assessed by single-cell RNA sequencing Cheng, Meiling

149 9 p. 5497-5512
artikel
53 Impact of breath-hold technique on incidence of cardiac events in adjuvant left breast cancer irradiation Mahmoud, Amr A.

149 9 p. 5853-5859
artikel
54 Impact of IDH1 mutation on clinical course of patients with intrahepatic cholangiocarcinoma: a retrospective analysis from a German tertiary center Kinzler, Maximilian N.

149 9 p. 6391-6398
artikel
55 Impact of patient nationality on the severity of early side effects after radiotherapy Köksal, Mümtaz

149 9 p. 5573-5582
artikel
56 Impact of physical activity on postural stability and coordination in children with posterior fossa tumor: randomized control phase III trial Usama, Mahmoud

149 9 p. 5637-5644
artikel
57 Implementing an immunotherapy toxicity (IOTOX) GI service improves outcomes in patients with immune-mediated diarrhea and colitis Saji, Alice

149 9 p. 5841-5852
artikel
58 Improving the performance status in advanced non-small cell lung cancer patients with chemotherapy (ImPACt trial): a phase 2 study Pathak, Neha

149 9 p. 6399-6409
artikel
59 Increase of the T-reg-recruiting chemokine CCL22 expression in a progressive course of cervical dysplasia Vattai, Aurelia

149 9 p. 6613-6623
artikel
60 Influence of neo-adjuvant radiotherapy on the intestinal microbiota of rectal cancer patients Xu, Siyang

149 9 p. 6085-6096
artikel
61 Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis Peng, Yongchun

149 9 p. 6097-6113
artikel
62 Interactive webtool for analyzing drug sensitivity and resistance associated with genetic signatures of cancer cell lines Boeschen, Myriam

149 9 p. 5539-5545
artikel
63 Intratumor microbiota: a novel tumor component Gong, Yanyu

149 9 p. 6675-6691
artikel
64 Investigation of miR-133a, miR-637 and miR-944 genes expression and their relationship with PI3K/AKT signaling in women with breast cancer Barartabar, Zeinab

149 9 p. 6115-6129
artikel
65 Involvement of angiogenesis in cancer-associated acinar-to-ductal metaplasia lesion of pancreatic cancer invasive front Fei, Shuang

149 9 p. 5885-5899
artikel
66 Is the sarcomatous component (homologous vs heterologous) the prognostic “driving force” in early-stage uterine carcinosarcomas? A retrospective multicenter study Rosati, A.

149 9 p. 6479-6488
artikel
67 KCMF1 regulates autophagy and ion channels’ function in renal cell carcinoma: a future therapeutic target Singh, Ashu

149 9 p. 5617-5626
artikel
68 Larysuicide: an online risk stratification system to identify patients at high risk of suicide after the laryngeal cancer diagnosis Tu, Zegui

149 9 p. 6455-6465
artikel
69 Lay etiology concepts of cancer patients do not correlate with their usage of complementary and/or alternative medicine Huebner, J.

149 9 p. 6067-6074
artikel
70 Matching-adjusted indirect comparison of asciminib versus other treatments in chronic-phase chronic myeloid leukemia after failure of two prior tyrosine kinase inhibitors Atallah, Ehab

149 9 p. 6247-6262
artikel
71 Mental burden and moral distress among oncologists and oncology nurses in Germany during the third wave of the COVID-19 pandemic: a cross-sectional survey Sommerlatte, Sabine

149 9 p. 6211-6223
artikel
72 Mitochondrial metabolism: a predictive biomarker of radiotherapy efficacy and toxicity Taghizadeh-Hesary, Farzad

149 9 p. 6719-6741
artikel
73 Monalizumab efficacy correlates with HLA-E surface expression and NK cell activity in head and neck squamous carcinoma cell lines Lee, Jeongjae

149 9 p. 5705-5715
artikel
74 MTA1 as negative prognostic marker in vulvar carcinoma Wanka, Giulia

149 9 p. 6191-6201
artikel
75 Nanobodies: a new potential for prostate cancer treatment Su, Jianfei

149 9 p. 6703-6710
artikel
76 Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial Alsaleh, K.

149 9 p. 6171-6179
artikel
77 Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread Sigorski, Dawid

149 9 p. 5803-5822
artikel
78 NOTCH3 missense mutations as predictor of long-term response to gemcitabine in a patient with epithelioid hemangioendothelioma Schmidt, Moritz

149 9 p. 6753-6757
artikel
79 Orelabrutinib and venetoclax synergistically induce cell death in double-hit lymphoma by interfering with the crosstalk between the PI3K/AKT and p38/MAPK signaling Pan, Guangchao

149 9 p. 5513-5529
artikel
80 Overview of m6A and circRNAs in human cancers Zhang, Leyu

149 9 p. 6769-6784
artikel
81 Pattern of recurrence and overall survival in esophagogastric cancer after perioperative FLOT and clinical outcomes in MSI-H population: the PROSECCO Study Nappo, Floriana

149 9 p. 6601-6611
artikel
82 Phase 1b study of intravenous coxsackievirus A21 (V937) and ipilimumab for patients with metastatic uveal melanoma Lutzky, Jose

149 9 p. 6059-6066
artikel
83 Pomalidomide combinations are a safe and effective option after daratumumab failure Brioli, Annamaria

149 9 p. 6569-6574
artikel
84 Prevalence and severity of anxiety in cancer patients: results from a multi-center cohort study in Germany Goerling, Ute

149 9 p. 6371-6379
artikel
85 Prognostic value of baseline and early response FDG-PET/CT in patients with refractory and relapsed aggressive B-cell lymphoma undergoing CAR-T cell therapy Georgi, Thomas Walter

149 9 p. 6131-6138
artikel
86 Prognostic value of MR-detected mandibular nerve involvement: potential indication for future individual induction chemotherapy in T4 nasopharyngeal carcinoma Huang, Wenjie

149 9 p. 5951-5964
artikel
87 Psychosocial distress in young adults surviving hematological malignancies: a pilot study Wittwer, Andreas

149 9 p. 5655-5663
artikel
88 RAI3 expression is not associated with clinical outcomes of patients with non-small cell lung cancer Melling, Nathaniel

149 9 p. 6549-6555
artikel
89 Reactivation of natural killer cells with monoclonal antibodies in the microenvironment of malignant neoplasms Soldi, Luiz Ricardo

149 9 p. 6661-6673
artikel
90 Requirement of image standardization for AI-based macroscopic diagnosis for surgical specimens of gastric cancer Sakashita, Shingo

149 9 p. 6467-6477
artikel
91 Role of Fyn in hematological malignancies Li, Shan

149 9 p. 6759-6767
artikel
92 Sarcopenia indicate poor survival in patients undergoing transarterial chemoembolization (TACE) for hepatic malignancies Loosen, Sven H.

149 9 p. 6181-6190
artikel
93 Severe neuromuscular immune-related adverse events of immune checkpoint inhibitors at national cancer center in Korea Hyun, Jae-Won

149 9 p. 5583-5589
artikel
94 Somatostatin-analog effect on pancreatic fistula after radical gastrectomy: a pilot randomized controlled trial Sha, Shengxu

149 9 p. 6329-6339
artikel
95 Suppression of exosomal hsa_circ_0001005 eliminates the Vemurafenib resistance of melanoma Wang, Xicheng

149 9 p. 5921-5936
artikel
96 Systematic analysis of mistletoe prescriptions in clinical studies Staupe, Henrike

149 9 p. 5559-5571
artikel
97 Targeted therapy for osteosarcoma: a review Li, Shizhe

149 9 p. 6785-6797
artikel
98 The antitumor effect of the novel agent MCL/ACT001 in pancreatic ductal adenocarcinoma Yang, Juan

149 9 p. 5717-5728
artikel
99 The basement membrane-related gene signature is associated with immunity and predicts survival accurately in hepatocellular carcinoma Zhao, Yu

149 9 p. 5751-5760
artikel
100 The correlation between the expression of ubiquitin-conjugating enzyme 2C and prostate cancer prognosis Kim, Jae Heon

149 9 p. 6351-6360
artikel
101 The debatable role of immune checkpoint blockade therapy in lung adenocarcinoma-oriented liver metastatic malignant lesions Qiu, Dan

149 9 p. 5791-5802
artikel
102 The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma Zhao, Lina

149 9 p. 6035-6048
artikel
103 The M2 macrophages infiltration of sebaceous tumors is linked to the aggressiveness of tumors but not to the mismatch repair pathway Frouin, Eric

149 9 p. 6445-6454
artikel
104 The positive feedback loop of MAD2L1/TYK2/STAT3 induces progression in B-cell acute lymphoblastic leukaemia Zhu, Liwen

149 9 p. 6527-6540
artikel
105 The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma Wang, Tian

149 9 p. 5627-5636
artikel
106 The usefulness of a three-protein signature blood assay (Mastocheck®) for follow-up after breast cancer surgery Kim, Yumi

149 9 p. 5733-5741
artikel
107 Total marrow irradiation versus total body irradiation using intensity-modulated helical tomotherapy Köksal, Mümtaz

149 9 p. 5965-5973
artikel
108 Tumor budding as an indicator for lymph node metastasis and prognosis of early gastric cancer Yao, Gaoyan

149 9 p. 5603-5616
artikel
109 Two germline mutations can serve as genetic susceptibility screening makers for a lung adenocarcinoma family Xiao, Ning

149 9 p. 6541-6548
artikel
110 Using a zebrafish xenograft tumor model to compare the efficacy and safety of VEGFR-TKIs Wanting, Hou

149 9 p. 5975-5987
artikel
111 Using deep learning to predict survival outcome in non-surgical cervical cancer patients based on pathological images Zhang, Kun

149 9 p. 6075-6083
artikel
112 Visceral adipose tissue secretome from early and late-stage oesophageal cancer patients differentially affects effector and regulatory T cells Davern, Maria

149 9 p. 6583-6599
artikel
113 Will repeat resection after initial transurethral en bloc resection benefit patients with high-risk non-muscle-invasive bladder cancer? A propensity score matching analysis Zhou, Mengqi

149 9 p. 5861-5869
artikel
114 Working situation and burden of work limitations in sarcoma patients: results from the multi-center prospective PROSa study Zapata Bonilla, Sergio Armando

149 9 p. 6009-6021
artikel
115 X-linked inhibitor of apoptosis protein is a prognostic marker for a favorable outcome in three identified subsets in resectable adenocarcinoma of the pancreas Knipper, Karl

149 9 p. 5531-5538
artikel
                             115 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland